An international research collaborative has determined that a promising anti-malarial compound tricks the immune system to rapidly destroy red blood cells infected with the malaria parasite but leave healthy cells unharmed.
St. Jude Children’s Research Hospital scientists led the study, which appears in the current online early edition of the Proceedings of the National Academy of Sciences (PNAS).
The compound, (+)-SJ733, was developed from a molecule identified in a previous St. Jude-led study that helped to jumpstart worldwide anti-malarial drug development efforts. Malaria is caused by a parasite spread through the bite of an infected mosquito. The disease remains a major health threat to more than half the world’s population, particularly children. The World Health Organization estimates that in Africa a child dies of malaria every minute.
In this study, researchers determined that (+)-SJ733 uses a novel mechanism to kill the parasite by recruiting the immune system to eliminate malaria-infected red blood cells. In a mouse model of malaria, a single dose of (+)-SJ733 killed 80 percent of malaria parasites within 24 hours. After 48 hours the parasite was undetectable.
Planning has begun for safety trials of the compound in healthy adults.
Laboratory evidence suggests that the compound’s speed and mode of action work together to slow and suppress development of drug-resistant parasites. Drug resistance has long undermined efforts to treat and block malaria transmission.
“Our goal is to develop an affordable, fast-acting combination therapy that cures malaria with a single dose,” said corresponding author R. Kiplin Guy, Ph.D., chair of the St. Jude Department of Chemical Biology and Therapeutics. “These results indicate that SJ733 and other compounds that act in a similar fashion are highly attractive additions to the global malaria eradication campaign, which would mean so much for the world’s children, who are central to the mission of St. Jude.”
Whole genome sequencing of the Plasmodium falciparum, the deadliest of the malaria parasites, revealed that (+)-SJ733 disrupted activity of the ATP4 protein in the parasites. The protein functions as a pump that the parasites depend on to maintain the proper sodium balance by removing excess sodium.
The sequencing effort was led by co-author Joseph DeRisi, Ph.D., a Howard Hughes Medical Institute investigator and chair of the University of California, San Francisco Department of Biochemistry and Biophysics. Investigators used the laboratory technique to determine the makeup of the DNA molecule in different strains of the malaria parasite.
Researchers showed that inhibiting ATP4 triggered a series of changes in malaria-infected red blood cells that marked them for destruction by the immune system. The infected cells changed shape and shrank in size. They also became more rigid and exhibited other alterations typical of aging red blood cells. The immune system responded using the same mechanism the body relies on to rid itself of aging red blood cells.
Another promising class of antimalarial compounds triggered the same changes in red blood cells infected with the malaria parasite, researchers reported. The drugs, called spiroindolones, also target the ATP4 protein. The drugs include NITD246, which is already in clinical trials for treatment of malaria. Those trials involve investigators at other institutions.
“The data suggest that compounds targeting ATP4 induce physical changes in the infected red blood cells that allow the immune system or erythrocyte quality control mechanisms to recognize and rapidly eliminate infected cells,” DeRisi said. “This rapid clearance response depends on the presence of both the parasite and the investigational drug. That is important because it leaves uninfected red blood cells, also known as erythrocytes, unharmed.”
Laboratory evidence also suggests that the mechanism will slow and suppress development of drug-resistant strains of the parasite, researchers said.
The Latest on: Malaria
via Google News
The Latest on: Malaria
- Just over $600M a year goes to malaria R&D. Can COVID-19 change that?on December 4, 2020 at 4:14 pm
Total malaria R&D investment from 2007-2018 was over $7 billion, with about $1.8 billion going to vaccine R&D. In comparison, U.S. investments in COVID-19 vaccine R&D this year through BARDA have ...
- Evolving malaria mosquitoes getting harder to controlon December 4, 2020 at 7:07 am
Anopheles malaria mosquitoes in Africa and Latin America are evolving in response to human activity, studies in both continents have found.
- SEE IT: David Beckham imagined as 70-year-old silver daddy for malaria public service announcementon December 3, 2020 at 8:29 pm
In a public service announcement for malaria eradication, 45-year-old soccer stud David Beckham is reimagined as a 70-year-old man speaking from the not-so-distance future addressing the disease’s ...
- David Beckham digitally aged into his 70s in combating malaria campaignon December 3, 2020 at 9:21 am
David Beckham is perhaps as famed for his looks as he is for his football career -- but a new campaign is showing him as you've never seen him before.
- David Beckham at 70: The Football Star Gets Digitally-Aged for Poignant ‘Malaria No More’ Adon December 3, 2020 at 8:58 am
David Beckham appears in a new advert like you’ve never seen him before, digitally aged to look like he’s in his 70s. Complete with wrinkles and a grey beard, he delivers a powerful message about ...
- How Amphibian Die-Offs Worsened Malaria Outbreakson December 2, 2020 at 7:54 pm
Researchers have found evidence that links the amphibian die-offs in the 1980s to a significant increase in malaria cases. The study shows how a change in the ecosystem can direct ...
- Amphibian die-offs worsened malaria outbreaks in Central Americaon December 2, 2020 at 9:38 am
The global collapse of frogs and other amphibians due to the amphibian chytrid fungus exacerbated malaria outbreaks in Costa Rica and Panama during the 1990s and 2000s, according to new research.
- Covid could derail efforts to eradicate malaria in Pacific, health experts warnon December 2, 2020 at 8:46 am
Region faces thousands of deaths if intervention measures disrupted as Australia urged to makes coronavirus vaccines available to neighbours ...
- WHO calls on global health partners to step up the fight against malariaon December 1, 2020 at 10:36 pm
The World Health Organization (WHO) is calling on countries and global health partners to step up the fight against malaria, a preventable and treatable disease that continues to claim hundreds of ...
- WHO: North Korea malaria cases trending downwardon December 1, 2020 at 6:39 am
Malaria is steadily declining in North Korea but more than 1 million North Koreans remain susceptible to the infectious disease, the World Health Organization said in a new report.
via Bing News